 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 February 1995 | Volume 122 Issue 3 | Pages 218-222
This essay reviews the rationale underlying host-directed or immune-based therapeutic strategies for human immunodeficiency virus (HIV) infection and its complications. These approaches have seen only limited trial in the past 10 years, but as more is learned about the immunopathogenesis of HIV disease and as the limitations of virus-directed therapies become more apparent, the need to pursue other therapeutic avenues has become increasingly important. Moreover, properly designed trials of host-directed and immune-based therapies can provide key insights into the pathogenesis of HIV disease that may be otherwise unattainable through in vitro studies.
Author and Article Information
From the AIDS Clinical Trials Unit, Case Western Reserve University and University Hospitals of Cleveland, Cleveland, Ohio.
PERSPECTIVE
Host-Directed and Immune-Based Therapies for Human Immunodeficiency Virus Infection
Requests for Reprints: Michael M. Lederman, MD, Department of Medicine/Division of Infectious Diseases, University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, OH 44106.
Acknowledgments: The author thanks Drs. Jerrold Ellner, Jonathan Kagan, Norman Letvin, and Robert Schooley for their thoughtful comments.
Grant Support: By the National Institutes of Health (AI 25879).
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  M. M. Lederman, A. Penn-Nicholson, M. Cho, and D. Mosier Biology of CCR5 and its role in HIV infection and treatment. JAMA, August 16, 2006; 296(7): 815 - 826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. F. Ansari and J. V. Etzel Immune-Based Therapies for the Management of HIV Infection: Highly Active Antiretroviral Therapy and Beyond Journal of Pharmacy Practice, December 1, 2000; 13(6): 515 - 532. [Abstract] [PDF]
|
|
|
|
 |
|
 J. A. Kovacs, S. Vogel, J. M. Albert, J. Falloon, R. T. Davey, R. E. Walker, M. A. Polis, K. Spooner, J. A. Metcalf, M. Baseler, et al. Controlled Trial of Interleukin-2 Infusions in Patients Infected with the Human Immunodeficiency Virus N. Engl. J. Med., October 31, 1996; 335(18): 1350 - 1356. [Abstract] [Full Text] [PDF]
|
|
Article
